| Breakdown | TTM | Feb 2025 | Feb 2024 | Aug 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 129.76M | 141.86M | 152.75M | 152.91M | 101.31M | 83.69M |
| Gross Profit | 13.74M | 17.86M | 18.60M | 18.35M | 9.63M | 6.92M |
| EBITDA | 14.13M | 15.75M | 14.14M | 14.24M | 13.05M | 9.98M |
| Net Income | 4.17M | 6.10M | 4.62M | 4.60M | 5.82M | 2.77M |
Balance Sheet | ||||||
| Total Assets | 153.64M | 157.42M | 161.57M | 177.94M | 149.64M | 158.30M |
| Cash, Cash Equivalents and Short-Term Investments | 20.67M | 20.48M | 27.95M | 34.73M | 13.96M | 14.11M |
| Total Debt | 34.30M | 34.58M | 34.72M | 36.39M | 35.93M | 51.33M |
| Total Liabilities | 69.89M | 73.26M | 81.95M | 101.26M | 78.15M | 91.79M |
| Stockholders Equity | 83.75M | 84.16M | 79.62M | 76.68M | 71.49M | 66.51M |
Cash Flow | ||||||
| Free Cash Flow | 1.95M | 5.33M | 4.65M | 21.28M | 19.30M | 12.20M |
| Operating Cash Flow | 2.76M | 5.94M | 5.18M | 22.06M | 20.47M | 13.35M |
| Investing Cash Flow | 877.00K | 1.29M | 1.49M | 6.67M | -5.87M | 5.22M |
| Financing Cash Flow | -9.17M | -15.05M | -12.08M | -10.60M | -15.08M | -32.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.91B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
75 Outperform | £1.44B | 17.83 | 12.93% | 2.89% | 3.29% | -8.76% | |
64 Neutral | £70.62M | 85.60 | 4.97% | 2.25% | -15.64% | -22.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | £236.68M | -42.97 | -2.37% | ― | -12.37% | ― | |
42 Neutral | £78.00M | -6.24 | -5.70% | 0.90% | 15.95% | -136.18% | |
40 Underperform | £1.60M | -0.05 | -52.46% | ― | 11.78% | -39.58% |